Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

PD-1

  • You have access
    Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
    NAOTO WAKITA, NOBUYUKI HINATA, YUKARI BANDO, TAKUTO HARA, TOMOAKI TERAKAWA, JUNYA FURUKAWA, YUZO NAKANO and MASATO FUJISAWA
    Anticancer Research February 2023, 43 (2) 841-847; DOI: https://doi.org/10.21873/anticanres.16226
  • You have access
    Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
    CHIERI NAKAYAMA, KIYONORI TANOUE, TETSUYA IDICHI, HIROKI SHIMOMURA, YOSHIAKI KITA, YUTO HOZAKA, YOSHIAKI SHINDEN, DAISUKE MATSUSHITA, AKIHIRO NAKAJO, TAKAAKI ARIGAMI, YUKO MATAKI, HIROSHI KURAHARA and TAKAO OHTSUKA
    Anticancer Research July 2022, 42 (7) 3373-3380; DOI: https://doi.org/10.21873/anticanres.15824
  • Open Access
    Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer
    THOMAS HECKING, THORE THIESLER, JANINA HALBE, LUCIA OTTEN, FLORIAN RECKER, HEIDRUN GEVENSLEBEN, TIM MÜLLER, CYNTHIA SCHILLER, EVA K. EGGER, ROLF FIMMERS, MATTHIAS B. STOPE, GLEN KRISTIANSEN and ALEXANDER MUSTEA
    Anticancer Research March 2022, 42 (3) 1367-1376; DOI: https://doi.org/10.21873/anticanres.15606
  • You have access
    The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment
    PRAJWAL NEUPANE, KOSAKU MIMURA, SHOTARO NAKAJIMA, HIROKAZU OKAYAMA, MISATO ITO, AUNG KYI THAR MIN, KATSUHARU SAITO, HISASHI ONOZAWA, SHOTARO FUJITA, WATARU SAKAMOTO, MOTONOBU SAITO, ZENICHIRO SAZE, TOMOYUKI MOMMA and KOJI KONO
    Anticancer Research October 2021, 41 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15303
  • You have access
    Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
    KUNIHIKO KOBAYASHI, KYOICHI KAIRA and HIROSHI KAGAMU
    Anticancer Research September 2020, 40 (9) 5309-5311; DOI: https://doi.org/10.21873/anticanres.14537
  • You have access
    Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion
    KENSUKE NISHI, SHUHEI ISHIKURA, MASAYO UMEBAYASHI, TAKASHI MORISAKI, TAKASHI INOZUME, TETSUSHI KINUGASA, MIKIKO AOKI, SATOSHI NIMURA, ANTHONY SWAIN, YOICHIRO YOSHIDA, SUGURU HASEGAWA, KAZUKI NABESHIMA, TOSHIFUMI SAKATA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA
    Anticancer Research August 2020, 40 (8) 4663-4674; DOI: https://doi.org/10.21873/anticanres.14465
  • You have access
    Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer
    HAYATO KAWACHI, DAICHI FUJIMOTO, DAISUKE YAMASHITA, JUNYA FUKUOKA, YUKA KITAMURA, KAZUTAKA HOSOYA, YUKI SATO, KAZUMA NAGATA, ATSUSHI NAKAGAWA, RYO TACHIKAWA, NAOKI DATE, ICHIRO SAKANOUE, HIROSHI HAMAKAWA, YUTAKA TAKAHASHI and KEISUKE TOMII
    Anticancer Research May 2019, 39 (5) 2561-2567; DOI: https://doi.org/10.21873/anticanres.13378
  • You have access
    Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
    DAICHI FUJIMOTO, DAISUKE YAMASHITA, JUNYA FUKUOKA, YUKA KITAMURA, KAZUTAKA HOSOYA, HAYATO KAWACHI, YUKI SATO, KAZUMA NAGATA, ATSUSHI NAKAGAWA, RYO TACHIKAWA, NAOKI DATE, ICHIRO SAKANOUE, HIROSHI HAMAKAWA, YUTAKA TAKAHASHI and KEISUKE TOMII
    Anticancer Research December 2018, 38 (12) 6891-6895; DOI: https://doi.org/10.21873/anticanres.13065
  • You have access
    PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma
    YING-MING CHIU, CHUNG-LIN TSAI, JUNG-TA KAO, CHIN-TUNG HSIEH, DONG-CHEN SHIEH, YI-JU LEE, GREGORY J. TSAY, KEN-SHENG CHENG and YI-YING WU
    Anticancer Research April 2018, 38 (4) 2069-2078;
  • You have access
    Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    HIROAKI SAITO, YUSUKE KONO, YUKI MURAKAMI, YUJI SHISHIDO, HIROHIKO KURODA, TOMOYUKI MATSUNAGA, YOJI FUKUMOTO, TOMOHIRO OSAKI, KEIGO ASHIDA and YOSHIYUKI FUJIWARA
    Anticancer Research January 2018, 38 (1) 107-112;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire